California Genetic Testing Company Agrees To Pay $8.25 Million To Resolve False Claims Allegations; Paducah, Ky, Area Hospital Also Settles
LOUISVILLE, Ky. - United States Attorney Russell Coleman today announced an $8.25 million settlement with Agendia, Inc., a molecular diagnostics testing company based in Irvine, California, for an alleged nationwide scheme to bill Medicare for Agendia's flagship genetic test, MammaPrint.
- Date:July 1, 2020
- Agency:U.S. Attorney's Office, Western District of Kentucky
- Criminal and Civil Actions